Cryptowerk selected for FDA DSCSA Pilot Program
“The Optimal Solution” is a team of seasoned industry innovators cooperatively leveraging their expertise to demonstrate interoperability at scale in the pharma supply chain ecosystem.
After a rigorous screening process, a team comprising six strategic technology partners has been selected to participate in a new Food and Drug Administration (FDA) pilot program aimed at making it easier for pharmaceutical companies to comply with the Drug Supply Chain Security Act (DSCSA). The pilot team includes supply chain technology leaders RXTransparent, Systech, T-Systems, FarmaTrust, Cryptowerk, and CalQLogic.
The Optimal Solutions team is hosting a live complimentary webinar on April 30th, 1:00 PM EDT to discuss the pilot submission.
“By leveraging our advanced technologies in a fully interoperable fashion, this pilot approach addresses product safety and trust issues beyond compliance. We believe we are creating a unique solution with an unmatched combination of partners as a viable blueprint for the whole industry,” says Peter Ebert, SVP at Cryptowerk.
The collective approach is designed to meet and excel regulatory requirements with a solution that includes:
- Utilizing a digital e-Fingerprint® layer of security to create an immutable track and trace ledger that improves visibility and enhances counterfeiting detection at the product level
- Capturing the Internet of Things (IOT) and Cold Chain information to leverage data for additional consumer insight and analytics
- Deploying blockchain as the infrastructure to enable interoperability providing a reliable foundation for trust in data that has been elusive with other technologies
The pilot duration is proposed as six months with the final FDA presentation anticipated for Fall 2019.